Related Experiment Videos
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease
S Bernard1, P LeBlanc, F Whittom
1Unité de Recherche, Institut de Cardiologie et de Pneumologie de Québec, Université Laval, Ste-Foy, Québec, Canada.
American Journal of Respiratory and Critical Care Medicine
|August 12, 1998
Summary
Peripheral muscle weakness in chronic obstructive pulmonary disease (COPD) is primarily due to muscle atrophy, not reduced strength relative to size. This impacts exercise capacity and is linked to disease severity and inactivity.
Area of Science:
- Pulmonary Medicine
- Muscle Physiology
- Exercise Science
Background:
- Peripheral muscle weakness is a common comorbidity in Chronic Obstructive Pulmonary Disease (COPD).
- This weakness can significantly impair exercise capacity in COPD patients.
- The underlying mechanisms and distribution of this weakness require further elucidation.
Purpose of the Study:
- To investigate the relationship between muscle strength and cross-sectional area (CSA) in COPD patients.
- To determine the distribution pattern of peripheral muscle weakness in COPD.
- To examine the correlation between muscle strength and the severity of lung disease in COPD.
Main Methods:
- Evaluated 34 COPD patients and 16 healthy controls.
- Assessed muscle strength and thigh muscle CSA using computed tomography.
- Analyzed the quadriceps strength/thigh muscle CSA ratio and compared muscle groups.
Main Results:
- COPD patients exhibited reduced muscle strength and thigh muscle CSA compared to controls.
- The quadriceps strength/thigh muscle CSA ratio was similar between groups, indicating muscle atrophy.
- Quadriceps weakness was more pronounced than shoulder girdle weakness and correlated with disease severity (FEV1).
Conclusions:
- Muscle weakness in COPD is primarily attributed to muscle atrophy rather than intrinsic strength deficits relative to muscle size.
- Peripheral muscle weakness distribution and its correlation with airflow obstruction suggest chronic inactivity contributes to muscle loss.
- These findings highlight the importance of addressing muscle deconditioning in COPD management.